ThursdayDec 05, 2024 8:45 am

Riding the Wave of the Next Commodity Supercycle

Within the past several years, commodity prices reached a 50-year low relative to equity valuations (https://ibn.fm/QrRMU). Historically, such lows in the commodity-to-equity ratio have marked the onset of new commodity supercycles—prolonged periods of sustained growth in raw material prices—and we’ve clearly seen the markets shifting with gold hitting all-time highs throughout much of this year. As global economic conditions evolve, commodities have been re-emerging as an important consideration when reconstructing investment portfolios. The last major commodity supercycle (1996–2011) was fueled by the industrialization of emerging economies like China, India and Brazil. Today, a combination of inflationary pressures, supply chain disruptions,…

Continue Reading

ThursdayDec 05, 2024 8:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Names New Board of Directors Member as Stock Price Hit 52-Week High

The company’s share price recently reached a 52-week high, a significant milestone that reflects a period of robust trading and investor optimism. D-Wave continues efforts to expand its board of directors with experienced tech executives to assist the company’s aggressive go-to-market strategy and accelerate adoption of its annealing quantum computing technology. The latest board addition, Sharon Holt, is a veteran technology executive, investor and board director with extensive global industry experience. D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has seen a remarkable share price surge…

Continue Reading

WednesdayDec 04, 2024 9:30 am

Astiva Health Inc. Expecting to Build Upon This Year’s Performance with Significant Membership Boost in 2025

The company anticipates a 70% increase in membership in the upcoming year, growing the current number of members from 13,000 in June 2024 to 20,000 in 2025. The fourfold increase in membership reflects the growing demand for a change in approach to healthcare that combines innovative personalized strategies with a deep understanding of the served communities. The company has established a strong network of over 12,940 providers, enabling it to offer comprehensive care to its rapidly growing member base, especially in Southern California. Astiva Health, a fast-growing Medicare Advantage Prescription Drug (“MAPD”) health plan, dedicated to reshaping personalized and comprehensive…

Continue Reading

WednesdayDec 04, 2024 8:45 am

Torr Metals Inc. (TSX.V: TMET) Distinguishing Itself: Driving New Exploration and Discovery in Canada’s Premier Mining Districts

In just over one year, Torr Metals has identified six undrilled gold anomalies covering a 1.2 x 2-kilometer (“km”) corridor, with gold soil grades up to 1.32 g/t Au along the Trans-Canada Highway; additional 2024 surface assays pending testing a highly prospective 7 km strike-length to potential mineralization At the 100% owned Kolos Copper-Gold Project, Torr’s inaugural soil sampling over the past year defined a 7 km porphyry trend with three undrilled copper-gold centers, boasting a footprint 33% larger than Copper Mountain Mine and double the average grades of regional deposits Investors can look forward to continued updates on upcoming…

Continue Reading

WednesdayDec 04, 2024 8:00 am

Thumzup Media Corp. (NASDAQ: TZUP) Is ‘One to Watch’

Thumzup offers a unique platform designed to democratize the multi-billion-dollar social media marketing industry. The company combines programmatic advertising with user-generated content to create high-impact campaigns. Thumzup achieved 202% growth in advertisers on its platform through October 2024, showcasing strong traction. Recent video integration with Instagram Reels enhances platform capabilities and expands advertiser options. The company operates in a rapidly growing market with strong long-term growth potential, led by an experienced leadership team. Thumzup (NASDAQ: TZUP) is at the forefront of modernizing the social media branding and marketing industry with its unique platform designed to connect advertisers directly with everyday…

Continue Reading

TuesdayDec 03, 2024 2:30 pm

Adageis Is ‘One to Watch’

Adageis operates in the rapidly expanding AI healthcare market, projected by Fortune Business Insights to reach $490.96 billion by 2032. The ProActive Care Platform offers seamless integration with existing EMR systems, reducing adoption barriers for healthcare providers. Partnerships with prominent organizations, such as HealthyU Clinics, and its status as an AthenaHealth marketplace partner, demonstrate Adageis’ growing influence in the healthcare sector. The company’s AI-driven predictive analytics enhance patient care and operational efficiency, aligning with the industry’s shift toward value-based care models. Led by a seasoned leadership team with extensive experience in healthcare and technology, Adageis is well-equipped to navigate the…

Continue Reading

TuesdayDec 03, 2024 8:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Completes Q3 2024 with Key Product Milestones, New Partnerships and Technological Breakthroughs

Among the most notable technical achievements was the completion of the calibration of a 4,400 qubit Advantage2(TM) processor, capable of solving much larger and complex problems with faster time-to-solution than earlier generation processors. D-Wave earned “awardable” status on the U.S. Department of Defense’s Tradewinds buying platform, gaining increased visibility with U.S. government customers. New partnerships and collaborations include working with NTT DOCOMO, Japan Tobacco Inc., Staque and the Chicago Quantum Exchange. D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, recently announced Q3 2024 business results, highlighting…

Continue Reading

TuesdayDec 03, 2024 8:00 am

Annovis Bio Inc. (NYSE: ANVS) to Present Recent Achievements and 2025 Strategic Outlook During Upcoming Live Investor Webcast

The webcast led by Annovis’ Founder, President and CEO, Maria Maccecchini, Ph.D., will take place on Dec. 11, at 4:30 p.m. EST. Dr. Maccecchini will provide a comprehensive view of the company’s recent achievements along with strategic initiatives for 2025, followed by a Q&A session. The company recently received FDA clearance to proceed with a pivotal Phase 3 Alzheimer’s disease program for lead drug candidate buntanetap, set to begin in early 2025. Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), will hold a…

Continue Reading

MondayDec 02, 2024 9:30 am

Financial Discipline and EM Client Expansion Drive Q3 Improvements for SuperCom Ltd. (NASDAQ: SPCB)

SuperCom’s superior electronic monitoring (“EM”) technology is highly competitive when it comes to tracking house arrest subjects and domestic violence offenders, allowing the company to expand its client base and revenue performance this year Israel-based SuperCom is improving law enforcement agencies’ capacity to monitor offenders on supervised release as a community-building and budget-conscious alternative to incarceration and to help reduce recidivism The company recently reported third-quarter financial information, including data on YoY revenue growth from $20.9 million to $21.3 million in the first 9 months and $6.78 million to $6.91 million during Q3. Also, the company reported on YoY EBITDA…

Continue Reading

MondayDec 02, 2024 8:00 am

Zomedica Corp (NYSE: ZOM) Featured in Coverage of NobleCon20

Zomedica (NYSE: ZOM) is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Their gold standard PulseVet(r) shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Their suite of products also includes the Assisi(r) Loop line of therapeutic devices and the TRUFORMA(r) diagnostic platform, the TRUVIEW(tm) digital cytology system, and the VetGuardian(r) no-touch monitoring system, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds $2 billion. Headquartered in Michigan, Zomedica employs approximately 150…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered